Previous close | 279.70 |
Open | 278.70 |
Bid | 275.60 x 40000 |
Ask | 277.80 x 40000 |
Day's range | 278.70 - 278.70 |
52-week range | 222.00 - 329.40 |
Volume | |
Avg. volume | 1 |
Market cap | 16.687B |
Beta (5Y monthly) | 0.97 |
PE ratio (TTM) | 29.84 |
EPS (TTM) | 9.34 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 361.75 |
72nd ASMS Conference on Mass Spectrometry and Allied Topics – Waters Corporation (NYSE: WAT) today unveiled the Xevo™ MRT, its highest-performing benchtop mass spectrometer (MS), setting new standards for delivering high resolution and speed, critical for large population and epidemiology-type studies. It builds on the innovative technology pioneered by the Waters SELECT SERIES™ MRT MS. The new Xevo MRT MS combines the raw power and resolution speed of multi-reflecting time-of-flight (MRT) and h
72nd ASMS Conference on Mass Spectrometry and Allied Topics – Waters Corporation (NYSE: WAT) announced that more than 40 products within its liquid chromatography (LC) chemistry portfolio have obtained Accountability, Consistency, and Transparency (ACT) Ecolabels from My Green Lab, a nonprofit organization dedicated to building a global culture of sustainability in science. For more than 50 years, Waters has built a world-class reputation as a single-source manufacturer of LC column chemistries,
On May 28, 2024, Director Richard Fearon purchased 1,000 shares of Waters Corp (NYSE:WAT), as reported in a recent SEC Filing.